ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

ClinicalTrials.gov ID: NCT06717698

Public ClinicalTrials.gov record NCT06717698. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 2:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy, Safety and Pharmacokinetics of NNC0519-0130 Once Weekly s.c. Versussemaglutide 1.0 mg and Placebo in People With Chronic Kidney Disease, With or Without Type 2 Diabetes, and With Overweight or Obesity: a Proof-of-concept and Dose-finding Study

Study identification

NCT ID
NCT06717698
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
465 participants

Conditions and interventions

Interventions

  • NNC0519-0130 Drug
  • Placebo Drug
  • Semaglutide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 1, 2024
Primary completion
Aug 31, 2026
Completion
Sep 16, 2026
Last update posted
Mar 10, 2026

2024 – 2026

United States locations

U.S. sites
18
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
N America Res Inst - San Dimas San Dimas California 91773 Active, not recruiting
NorCal Endocrinology and Internal Medicine San Ramon California 94583 Active, not recruiting
Rocky Mount Reg VA Med-DN Aurora Colorado 80045 Completed
Northeast Research Institute Fleming Island Florida 32003 Active, not recruiting
Encore Medical Research LLC Hollywood Florida 33024 Active, not recruiting
Northeast Research Institute Saint Augustine Florida 32080 Active, not recruiting
Clinical Research of Cent FL Winter Haven Florida 33880 Completed
Endeavor Health Skokie Illinois 60077 Completed
Velocity Clin. Res Valparaiso Valparaiso Indiana 46383 Active, not recruiting
Elite Research Center Flint Michigan 48532 Completed
Clinical Research Consultants Kansas City Missouri 64111-5964 Active, not recruiting
Albany Medical College Albany New York 12203 Active, not recruiting
Carteret Medical Group Morehead City North Carolina 28557 Active, not recruiting
Brookview Hills Research Associates, LLC Winston-Salem North Carolina 27103 Active, not recruiting
Davita Clinical Research El Paso Texas 79902 Active, not recruiting
Clinical Advancement Center San Antonio Texas 78212 Active, not recruiting
Tekton Research San Antonio Texas 78251 Completed
Providence Medical Research Center Spokane Washington 99204 Active, not recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 117 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06717698, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 10, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06717698 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →